# T2D & Bone Density, Microarchitecture, & Strength; Early Weight Loss, Glucose Tolerance, & Long-Term Mortality/CVD Risk; and more!

Page: https://stenobird.com/podcast/doc-updates-200053/t2d-bone-density-microarchitecture-strength-early-weight-loss-glucose-tolerance-long-term-mortality-cvd-risk-and-more
Text version: https://stenobird.com/podcast/doc-updates-200053/t2d-bone-density-microarchitecture-strength-early-weight-loss-glucose-tolerance-long-term-mortality-cvd-risk-and-more.md
Podcast: [DOC Updates](https://stenobird.com/podcast/doc-updates-200053)
Published: 2026-09-24T14:00:00+00:00
Episode link: https://diabetescoreupdate.libsyn.com/t2d-bone-density-microarchitecture-strength-early-weight-loss-glucose-tolerance-long-term-mortalitycvd-risk-and-more
Audio file: https://traffic.libsyn.com/secure/diabetescoreupdate/DOC-Updates-October-2026.mp3?dest-id=159994
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/t2d-bone-density-microarchitecture-strength-early-weight-loss-glucose-tolerance-long-term-mortality-cvd-risk-and-more
Duration seconds: 1964

## Resource

Welcome to the latest episode (October 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates : Zoungas et al; Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults . New England Journal of Medicine, 28 August 2026; doi.org/10.1056/NEJMoa2607314 Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) , press release N. Kruger, et al; Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study . BMJ 2026; 394 doi.org/10.1136/bmj-2026-100011 Dufour, et al; Type 2 Diabetes and Longitudinal Changes in Cortical and Trabecular Bone Density, Microarchitecture, and Strength: The Framingham Study . Diabetes Care 2026; dc260846. doi.org/10.2337/dc26-0846 He, et al; Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome Study . Diabetes Care 2026; dc260689. doi.org/10.2337/dc26-0689 Leavens ELS, Pebley K, Smith TT, et al; Nicotine E-Cigarettes for Cigarette Smoking Cessation: Recommendations to US-Based Clinicians . JAMA . 2026;336(9):783–790. doi.org/10.1001/jama.2026.13087 Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health DOC Updates is…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/t2d-bone-density-microarchitecture-strength-early-weight-loss-glucose-tolerance-long-term-mortality-cvd-risk-and-more/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/doc-updates-200053/t2d-bone-density-microarchitecture-strength-early-weight-loss-glucose-tolerance-long-term-mortality-cvd-risk-and-more.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.